Clinical Trial Update: mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mRNA-electroporated autologous dendritic cells for stage III/IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• mRNA-electroporated autologous dendritic cells

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Malignant Melanoma Stage III, Malignant Melanoma Stage IV | Phase 2 | Status: COMPLETED